WebSify
Follow us on
Mail
Print

News Summary: Pfizer painkiller patent extended

Source : AP
Last Updated: Wed, Mar 06, 2013 00:15 hrs

: Drugmaker Pfizer gets an 18-month extension on a key patent for its blockbuster anti-inflammatory painkiller, as the federal government grants a new patent for Celebrex. It replaces a patent invalidated by a federal appeals court due to technical deficiencies.

THE IMPACT: The new patent for Celebrex, Pfizer's fifth-best-selling drug, runs till December 2015. The additional time could bring Pfizer a few billion in extra revenue.

BACKSTOPPPING: Pfizer also is suing five generic drugmakers who had hoped to start selling generic Celebrex in May 2014, to prevent any generic sales by them until December 2015.




blog comments powered by Disqus
most popular on facebook
talking point on sify finance